Bank of America
RNTX

Bank of America’s Rein Therapeutics RNTX Stock Holding History

Bank of America’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42
Closed -$49 – 7143
2025
Q4 		$49 Sell
42
-58
-58% -$80 ﹤0.01% 6965
2025
Q3 		$115 Sell
100
-162
-62% -$206 ﹤0.01% 7828
2025
Q2 		$367 Buy
262
+21
+9% +$38 ﹤0.01% 7720
2025
Q1 		$427 Sell
241
-43
-15% -$90 ﹤0.01% 7542
2024
Q4 		$654 Sell
284
-1
-0.4% -$3 ﹤0.01% 7362
2024
Q3 		$1.01K Sell
285
-7
-2% -$19 ﹤0.01% 7240
2024
Q2 		$809 Buy
292
+167
+134% +$686 ﹤0.01% 7268
2024
Q1 		$829 Hold
125
– – ﹤0.01% 7226
2023
Q4 		$381 Hold
125
– – ﹤0.01% 7309
2023
Q3 		$190 Hold
125
– – ﹤0.01% 7415
2023
Q2 		$224 Sell
125
-15
-11% -$23 ﹤0.01% 7377
2023
Q1 		$174 Sell
140
-43
-23% -$92 ﹤0.01% 7439
2022
Q4 		$433 Sell
183
-2
-1% -$7 ﹤0.01% 7453
2022
Q3 		$1K Hold
185
– – ﹤0.01% 7706
2022
Q2 		$1K Sell
185
-200
-52% -$1.84K ﹤0.01% 7905
2022
Q1 		$4K Sell
385
-6
-2% -$54 ﹤0.01% 7945
2021
Q4 		$4K Sell
391
-171
-30% -$2.64K ﹤0.01% 7897
2021
Q3 		$11K Sell
562
-25
-4% -$548 ﹤0.01% 7558
2021
Q2 		$15K Buy
587
+46
+9% +$1.15K ﹤0.01% 7219
2021
Q1 		$15K Sell
541
-50
-8% -$1.71K ﹤0.01% 6941
2020
Q4 		$12K Sell
591
-21
-3% -$525 ﹤0.01% 6692
2020
Q3 		$16K Buy
612
+172
+39% +$4.05K ﹤0.01% 6344
2020
Q2 		$10K Buy
440
+10
+2% +$163 ﹤0.01% 6446
2020
Q1 		$3K Buy
430
+21
+5% +$253 ﹤0.01% 6592
2019
Q4 		$5K Sell
409
-121
-23% -$1.19K ﹤0.01% 6774
2019
Q3 		$7K Sell
530
-280
-35% -$3.87K ﹤0.01% 6795
2019
Q2 		$12K Sell
810
-189
-19% -$4.96K ﹤0.01% 6683
2019
Q1 		$39K Sell
999
-605
-38% -$18.8K ﹤0.01% 6289
2018
Q4 		$27K Sell
1,604
-884
-36% -$35.5K ﹤0.01% 6411
2018
Q3 		$137K Buy
2,488
+1,333
+115% +$89.7K ﹤0.01% 5710
2018
Q2 		$125K Buy
1,155
+612
+113% +$69.3K ﹤0.01% 5672
2018
Q1 		$88K Buy
543
+133
+32% +$23.7K ﹤0.01% 5786
2017
Q4 		$86K Sell
410
-100
-20% -$24K ﹤0.01% 5810
2017
Q3 		$136K Sell
510
-32,899
-98% -$8.25M ﹤0.01% 5553
2017
Q2 		$7.45M Buy
+33,409
New +$7.33M ﹤0.01% 2663

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Bank of America's RNTX Position: Q1 2026 in Review

Bank of America sold out of Rein Therapeutics (RNTX) in Q1 2026, closing a stake of 42 shares — an estimated $49 sold.

Bank of America first reported a position in RNTX in Q2 2017 and held it in 35 quarters. The position peaked at $7.45M in Q2 2017. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Bank of America reported no remaining Rein Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 42 Rein Therapeutics shares in Q1 2026, an estimated $49.
  • Bank of America first reported a position in Rein Therapeutics in Q2 2017 and held it in 35 quarters.
  • Bank of America's Rein Therapeutics position peaked at $7.45M in Q2 2017.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.